| Literature DB >> 36011209 |
João P Duarte1,2, Ricardo J Fernandes1,3, Gonçalo Silva1,3, Filipa Sousa1,3, Leandro Machado1,3, João R Pereira4, João P Vilas-Boas1,3.
Abstract
This review aims to understand the different technologies incorporated into lower limbs wearable smart garments and their impact on post-exercise recovery. Electronic searches were conducted in the PubMed, Web of Science, and Cochrane electronic databases. Eligibility criteria considered meta-analyses that examined the effects of wearable smart garments on physical fitness in healthy male and female adults. Seven meta-analyses were considered in the current umbrella review, indicating small effects on delayed-onset muscle soreness ([0.40-0.43]), rate of perceived exertion (0.20), proprioception (0.49), anaerobic performance (0.27), and sprints ([0.21-0.37]). The included meta-analyses also indicated wearable smart garments have trivial to large effects on muscle strength and power ([0.14-1.63]), creatine kinase ([0.02-0.44]), lactate dehydrogenase (0.52), muscle swelling (0.73), lactate (0.98) and aerobic pathway (0.24), and endurance (0.37), aerobic performance (0.60), and running performance ([0.06-6.10]). Wearing wearable smart garments did not alter the rate of perceived exertion and had a small effect on delayed-onset muscle soreness. Well-fitting wearable smart garments improve comfort and kinesthesia and proprioception and allow a reduction in strength loss and muscle damage after training and power performance following resistance training or eccentric exercise.Entities:
Keywords: exercise; fatigue; heating; injury; muscle damage (DOMS); recovery; wearable textile
Year: 2022 PMID: 36011209 PMCID: PMC9408502 DOI: 10.3390/healthcare10081552
Source DB: PubMed Journal: Healthcare (Basel) ISSN: 2227-9032
Information on the literature search, selection criteria, and considered moderator variables.
| Literature Search | Search Syntax | (garment OR tight OR stocking OR garments OR tights OR stockings) AND (compression OR recovery OR heat OR electrostimulation OR massage) AND (exercise OR EIMD OR performance OR recovery OR sport OR athlete) AND (meta-analysis) |
| Selection criteria | Population | Healthy adults (mean age > 18 years) |
| Intervention | Lower limbs garments using different associated recovery methods (e.g., compression, massage, electrostimulation, or heat) | |
| Comparator | Control groups or groups that have been subject to different recovery protocols | |
| Outcome | At least one measure of muscle strength, muscle power, linear sprint speed, sprint/speed/agility, blood lactate concentration, creatine kinase, rate of perceived exertion, and delayed-onset muscle soreness | |
| Study design | Meta-analysis | |
| Potential moderator variables | Chronological age | Adults |
General characteristics of the included systematic review and meta-analyses studies.
| Study | Design | Age | Included Studies | Sample Size | Garment Recovery Method | Outcome | AMSTAR Quality |
|---|---|---|---|---|---|---|---|
| Brown et al. (2017) [ | Meta-analysis | 25.0 ± 9.0 | 23 | 348 | Compression | Muscle strength and power, endurance, and sprints | Moderate |
| Ghai et al. (2016) [ | Meta-analysis | 28.0 ± 15.0 | 50 | 1443 | Joint stabilizers | Proprioception | Moderate |
| Hill et al. (2014) [ | Meta-analysis | 22.3 ± 2.3 | 12 | 205 | Compression | Delayed-onset muscle soreness, muscle strength, and creatine kinase | Moderate |
| Marques-Jimenez et al. (2016) [ | Meta-analysis | 23.6 ± 3.0 | 20 | 279 | Compression | Blood lactate concentration, creatine kinase, lactate dehydrogenase, muscle swelling, strength and power, and delayed-onset muscle soreness | Moderate |
| da Silva et al. (2018) [ | Meta-analysis | 29.5 ± 5.9 | 23 | 294 | Compression | Running time, maximal oxygen uptake, and rate of perceived exertion | High |
| Douzi et al. (2019) [ | Meta-analysis | NR | 45 | 473 | Cooling | Aerobic and anaerobic performances | Moderate |
| Altarriba-Bartes et al. (2020) [ | Meta-analysis | 20.8 ± 1.3 | 5 | 69 M | Compression | Counter movement jump, 20 m sprint, and maximal voluntary contraction | Moderate |
Abbreviations: Standard deviation (SD), not reported (NR), males (M), and females (F).
Quality of evidence for each outcome of the included meta-analyses using Grading of Recommendations Assessment, Development and Evaluation (GRADE).
| Meta-Analysis | Outcome | GRADE Items | Quality of the Evidence | ||||
|---|---|---|---|---|---|---|---|
| Risk of Bias | Inconsistency | Indirectness | Imprecision | Publication Bias | |||
| Brown et al. (2017) [ | Muscle strength | Serious | Serious | No serious | No serious | Not reported | Very low |
| Muscle power | Serious | No serious | No serious | ||||
| Endurance | Serious | No serious | No serious | ||||
| Sprints | Serious | No serious | No serious | ||||
| Ghai et al. (2016) [ | Proprioception | No serious | No serious | No serious | No serious | Likely | Moderate |
| Hill et al. (2014) [ | Delayed onset of muscle soreness | No blinding | No serious | No serious | No serious | Not reported | Low |
| Muscle strength | No serious | No serious | No serious | ||||
| Creatine kinase | No serious | No serious | No serious | ||||
| Marques-Jimenez et al. (2016) [ | Blood lactate concentration | Serious | Serious | No serious | No serious | Not reported | Very low |
| Creatine kinase | Serious | Serious | No serious | No serious | |||
| Lactate dehydrogenase | Serious | Serious | No serious | No serious | |||
| Muscle swelling | Serious | Serious | No serious | No serious | |||
| Muscle strength | Serious | Serious | No serious | No serious | |||
| Muscle power | Serious | Serious | No serious | No serious | |||
| Delayed onset of muscle soreness | Serious | Serious | No serious | No serious | |||
| da Silva et al. (2018) [ | Running performance | No blinding | Serious | No serious | No serious | Undetected | Moderate |
| Maximal oxygen uptake | Serious | No serious | No serious | ||||
| Rate of perceived exertion | Serious | No serious | No serious | ||||
| Douzi et al. (2019) [ | Aerobic performance | Serious | No serious | No serious | No serious | Likely | Moderate |
| Anaerobic performance | No serious | No serious | No serious | ||||
| Altarriba-Bartes et al. (2020) [ | Counter movement jump | Serious (−1) | No serious | No serious | No serious | Undetected | Moderate |
| 20 m sprint | No serious | No serious | No serious | ||||
| Maximal voluntary contraction | Serious (−1) | No serious | No serious | ||||
Included meta-analyses that examined the effects of smart compression garments on physiological outcomes in healthy adults.
| Meta-Analysis | Outcome | Effect Size/Mean Difference (95% CI, | Prediction Interval |
|---|---|---|---|
| Brown et al. (2017) [ | Muscle strength | Mean difference: 0.37 (0.22–0.51, n.a.); 66% (n.a., | 0.37 (−1.12–1.86) |
| Muscle power | |||
| Endurance | |||
| Sprints | |||
| Ghai et al. (2016) [ | Proprioception | Hedge’s g: 0.49 (0.36–0.62, | 0.49 (−1.54–2.52) |
| Hill et al. (2014) [ | Delayed-onset muscle soreness | Hedge’s g: 0.40 (0.24–0.57, | 0.40 (−1.16–1.96) |
| Muscle strength | Hedge’s g: 0.46 (0.22–0.70, | 0.46 (−1.37–2.29) | |
| Muscle power | Hedge’s g: 0.49 (0.27–0.71, | 0.49 (−1.32–2.30) | |
| Creatine kinase | Hedge’s g: 0.44 (0.17–0.70, | 0.44 (−1.36–2.24) | |
| Marques-Jimenez et al. (2016) [ | Blood lactate concentration | Mean difference: 0.98 (0.28–1.68, n.a.); 80% (60.48, | 0.98 (−1.98–3.94) |
| Creatine kinase | Mean difference: −0.02 (−0.44–0.40, n.a.); 83% (166.24, | 0.02 (−1.37–1.41) | |
| Lactate dehydrogenase | Mean difference: −0.52 (−1.42–0.38, n.a.); 81% (26.83, | 0.52 (−2.72–3.76) | |
| Muscle swelling | Mean difference: −0.73 (−1.20–−0.26, n.a.); 75% (75.58, | 0.73 (−1.04–2.50) | |
| Muscle strength | Mean difference: 1.18 (0.84–1.51, n.a.); 78% (196.08, | 1.18 (−1.36–3.72) | |
| Muscle power | Mean difference: 1.63 (1.10–2.16, n.a.); 85% (195.84, | 1.63 (−1.38–4.64) | |
| Delayed-onset muscle soreness | Mean difference: −0.43 (−0.66–−0.19, n.a.); 68% (148.60, | 0.43 (−0.27–1.13) | |
| da Silva et al. (2018) [ | Running performance 50–400 m | Mean difference: 0.06 (1.99–2.11, n.a.); 0% (n.a., | 0.06 (−5.52–5.64) |
| Running performance 800–3000 m | Mean difference: 6.10 (−7.23–19.43, n.a.); 0% (n.a., | 6.10 (−12.23–24.43) | |
| Running performance >5000 m | Mean difference: 1.01 (−84.80–86.82, n.a.); 0% (n.a., | 1.01 (−123.27–125.00) | |
| Maximal oxygen uptake | Mean difference: 0.24 (−1.48–1.95, n.a.); 0% (n.a., | 0.24 (−3.39–3.87) | |
| Rate of perceived exertion | Mean difference: −0.20 (−0.48–0.08, n.a.); 0% (n.a., | 0.20 (−0.76–1.16) | |
| Douzi et al. (2019) [ | Aerobic performance | Mean difference: 0.60 (0.43–0.77, n.a.); 36% (n.a., | 0.60 (−1.49–2.69) |
| Anaerobic performance | Mean difference: 0.27 (0.04–0.50, n.a.); 31% (n.a., | 0.27 (−1.42–1.96) | |
| Altarriba-Bartes et al. (2020) [ | Counter movement jump 24 h | Mean difference: 0.14 (−0.31–0.59, n.a.); 0% (n.a., | 0.14 (−10.05–10.32) |
| Counter movement jump 48 h | Mean difference: 0.69 (0.14–1.25, n.a.); 27% (n.a., | 0.69 (−13.96–15.34) | |
| 20 m sprint 24 h | Mean difference: −0.28 (−0.81–0.24, n.a.); 0% (n.a., | n.c. | |
| 20 m sprint 48 h | Mean difference: −0.21 (−0.74–0.31, n.a.); 0% (n.a., | n.c. | |
| Maximal voluntary contraction 24 h | Mean difference: 0.57 (−1.10–2.25, n.a.); 88% (n.a., | n.c. | |
| Maximal voluntary contraction 48 h | Mean difference: 0.23 (−0.39–0.84, n.a.); 0% (n.a., | n.c. |
Abbreviations: CI (confidence interval); n.a. (not applicable); n.c. (not computable).
Figure 1PRISMA flow chart representing the study screening and selection process.